Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2008 16:35 ET | Source: XOMA Royalty Corporation

New Programs Added in Antibody Collaboration Between XOMA and Takeda

BERKELEY, Calif., Sept. 15, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today the initiation of new therapeutic...
August 11, 2008 16:05 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Announces Second Quarter 2008 Results

SOUTH SAN FRANCISCO, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
August 07, 2008 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports Second Quarter 2008 Financial Results

REDWOOD CITY, Calif., Aug. 7, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the second quarter ended June 30, 2008. The net loss for the...
August 04, 2008 12:31 ET | Source: DelSite, Inc.

DelSite Subsidiary Sabila Industrial in Costa Rica Completes ISO 9001:2000 Inspection

* Sabila Industrial ISO-Certified for More Than Five Years * No Significant Incidences of Nonconformance Found * Continued Dedication to Quality IRVING, Texas, Aug....
July 31, 2008 12:18 ET | Source: Pharsight Corporation

Global Biotechnology Company Licenses WinNonlin AutoPilot

MOUNTAIN VIEW, Calif., July 31, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
July 29, 2008 13:45 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Results From a Phase 1 Study of M118 Administered as a Subcutaneous Injection

CAMBRIDGE, Mass., July 29, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
July 02, 2008 08:30 ET | Source: Athersys, Inc.

Athersys Added to Russell Microcap Index

CLEVELAND, July 2, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it was added to the Russell Microcap(r) Index when Russell Investments reconstituted its comprehensive family...
June 26, 2008 08:59 ET | Source: DelSite, Inc.

DelSite Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate

* Safer and More Economical Approach Against a Major Infectious Disease That Causes 500,000 to 600,000 Deaths Worldwide Per Year * Chemical Composition Similar to Marketed Typhoid...
August 11, 2005 07:07 ET | Source: Biotage AB

Biotage has Received its Largest Order to Date

STOCKHOLM, Sweden, Aug. 11, 2005 (PRIMEZONE) -- Biotage has received the company's largest single order to date. It includes 31 instruments and totals approx. 15 MSEK. The customer is one of the...
June 28, 2005 02:07 ET | Source: Crucell N.V.

Fidelity Fund Acquires 5.13 Percent Interest in Crucell

LEIDEN, Netherlands, June 28, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Fidelity's FID Growth Company Fund has acquired a 5.13%...